Protagenic Therapeutics Successfully Concludes Third Cohort in Single Dose Portion of Phase 1 Trial for Stress-Related Neuropsychiatric Disorders
Accesswire
*Next clinical progress update expected in April 2024*
*NEW YORK, NY / ACCESSWIRE / March 27, 2024 /* Protagenic..